Pregaba Capsule

About Pregaba 50 mg Capsule

Pregaba is a capsule medicine made by Opsonin Pharma Limited that contains pregabalin. It is used in adults for certain types of nerve pain and some other conditions, and it can also be added to seizure treatment in some age groups.

There are 105 brands of Pregabalin listed in Bangladesh. 12 of them have a lower unit price than Pregaba. The lowest listed price is GAPA-P 150 mg Capsule at ৳ 1 per unit.

What is Pregaba 50 mg Capsule?

Pregaba contains pregabalin, which acts on specific sites on calcium channels in the nervous system. This action is thought to help reduce pain signals and dampen overactive nerve activity. Pregabalin is used for nerve pain linked to diabetes or shingles, for fibromyalgia, for nerve pain after spinal cord injury, and as an add-on treatment for partial-onset seizures in some age groups. Pregaba is a 50 mg capsule. The dose and course are decided by your doctor, because they depend on your condition and response.

Uses of Pregaba

Pregaba is used for neuropathic pain from diabetic peripheral neuropathy, for postherpetic neuralgia after shingles, and for nerve pain linked to spinal cord injury. It is also used for fibromyalgia and as add-on therapy for partial-onset seizures in patients aged one month and older. It belongs to a group of adjunct anti-epileptic medicines. Whether it suits you depends on your condition, so ask your doctor.

How to use Pregaba

Take Pregaba exactly as your doctor tells you. The doctor decides the dose, how often you take it and how long the course lasts. Do not change the amount or stop it on your own, because stopping suddenly can cause problems. If you miss a dose, ask your doctor or pharmacist what to do. Swallow the capsule as advised by your doctor or pharmacist; they will guide you.

Side effects of Pregaba

Common side effects in adults include dizziness, sleepiness, dry mouth, swelling, blurred vision, weight gain and difficulty concentrating. In children treated for partial-onset seizures, increased weight and increased appetite are common. Tell your doctor if side effects bother you or do not settle. Some serious reactions can occur, so seek medical help for swelling of the throat, head or neck, hives, trouble breathing or wheezing, or any worrying change in mood or behaviour.

Safety and precautions

Do not take Pregaba if you are allergic to pregabalin or any of its ingredients. Talk to your doctor before use if you have breathing problems, kidney problems or a history of mood problems, or if you take other medicines that make you sleepy. Antiepileptic drugs, including pregabalin, can increase the risk of suicidal thoughts or behaviour, so tell your doctor about any such changes. There are no adequate and well-controlled studies in pregnant women; pregnant women should be told of the potential risk to a fetus. Breastfeeding is not recommended during treatment. Ask your doctor first if you are pregnant, planning pregnancy or breastfeeding.

Frequently asked questions

How should Pregaba be taken?

Take it as your doctor directs. The doctor decides the dose, how often it is taken and how long you take it. Do not change the dose or stop suddenly without medical advice. Ask your doctor or pharmacist about missed doses or any concerns.

What is Pregaba used for and what kind of medicine is it?

Pregaba contains pregabalin and belongs to a group of adjunct anti-epileptic medicines. It is used for certain nerve pain, fibromyalgia, and as add-on treatment for partial-onset seizures in some age groups. Your doctor will decide whether it is suitable for you.

What do the dosage form and strength mean?

Pregaba is a capsule, which is a solid dosage form you swallow. The strength is 50 mg, meaning each capsule contains 50 mg of pregabalin. The pack label shows 3 x 10. Ask your doctor or pharmacist how this strength fits your treatment.

What is the price of Pregaba?

The listed price is ৳ 15.00. Ask your pharmacist to confirm the current price, as it can change.

Indications

Pregabalin is indicated for:
  • Neuropathic pain associated with diabetic peripheral neuropathy (DPN)
  • Postherpetic neuralgia (PHN)
  • Adjunctive therapy for the treatment of partial-onset seizures in patients 1 month of age and older
  • Fibromyalgia
  • Neuropathic pain associated with spinal cord injury
  • ... Read more
Pregabalin is indicated for:
  • Neuropathic pain associated with diabetic peripheral neuropathy (DPN)
  • Postherpetic neuralgia (PHN)
  • Adjunctive therapy for the treatment of partial-onset seizures in patients 1 month of age and older
  • Fibromyalgia
  • Neuropathic pain associated with spinal cord injury
Pregabalin CR tablet is indicated for:
  • Neuropathic pain associated with diabetic peripheral neuropathy (DPN)
  • Postherpetic neuralgia (PHN)

Pharmacology

Pregabalin is a structural derivative of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA). It does not bind directly to GABAA, GABAB or benzodiazepine receptors. Pregabalin binds with high affinity to the alpha2-delta site (an auxiliary subunit of voltage-gated calcium channels) in central nervous system tissues. Although the mechanism of action of Pregabalin has not been fully elucidated, results in animal studies suggest that binding to the alpha2-delta subunit may be involved in Pregabalin's anti-nociceptive and antiseizure effects.

Dosage & Administration

Neuropathic pain associated with diabetic peripheral neuropathy in adults (DPN): The maximum recommended dose of Pregabalin is 100 mg three times a day (300 mg/day) in patients with creatinine clearance of at least 60 ml/min. Dosing should begin at 50 mg three times a day (150 mg/day). The dose may be increased to 300 mg/day within 1 week based on efficacy and tolerability. Begin dosing of Pregabalin CR capsule at 165 mg once daily and increase to 330 mg once daily within 1 week based on individual patient response and tolerability. The maximum recommended dose of Pregabalin CR capsule is 330 mg once daily.

Postherpetic neuralgia in adults (PHN): The recommended dose of Pregabalin is 75 to 150 mg two times a day or 50 to 100 mg three times a day (150 to 300 mg/day) in patients with creatinine clearance of at least 60 ml/min. Dosing should begin at 75 mg two times a day or 50 mg three times a day (150 mg/day). The dose may be increased to 300 mg/day within 1 week based on efficacy and tolerability. Patients who do not experience sufficient pain relief following 2 to 4 weeks of treatment with 300 mg/day and who are able to tolerate Pregabalin, may be treated with up to 300 mg two times a day or 200 mg three times a day (600 mg/day).

Begin dosing of Pregabalin CR capsule at 165 mg once daily and increase to 330 mg once daily within 1 week based on individual patient response and tolerability. Patients who do not experience sufficient pain relief following 2 to 4 weeks of treatment with 330 mg once daily and who are able to tolerate Pregabalin CR capsule, may be treated with up to 660 mg once daily. In view of the dose-dependent adverse reactions and the higher rate of treatment discontinuation due to adverse reactions, dosing above 330 mg/day should be reserved only for those patients who have on-going pain and are tolerating 330 mg daily. The maximum recommended dose of Pregabalin CR capsule is 660 mg once daily.

Management of fibromyalgia in adults: The recommended dose of Pregabalin is 300 to 450 mg/day. Dosing should begin at 75 mg two times a day (150 mg/day). The dose may be increased to 150 mg two times a day (300 mg/day) within 1 week based on efficacy and tolerability. Patients who do not experience sufficient benefit with 300 mg/day may be further increased to 225 mg two times a day (450 mg/day).

Neuropathic pain associated with spinal cord injury in adults: The recommended dose range of Pregabalin is 150 to 600 mg/day. The recommended starting dose is 75 mg two times a day (150 mg/day). The dose may be increased to 150 mg two times a day (300 mg/day) within 1 week based on efficacy and tolerability. Patients who do not experience sufficient pain relief after 2 to 3 weeks of treatment with 150 mg two times a day and who tolerate Pregabalin may be treated with up to 300 mg two times a day.

Conversion from Pregabalin capsules to Pregabalin CR capsule tablet: When switching from Pregabalin capsules to Pregabalin CR capsule tablet on the day of the switch, instruct patients to take their morning dose of Pregabalin capsule as prescribed and initiate Pregabalin CR capsule therapy after an evening meal.

Pregabalin tablet total daily dose (dosed 2 or 3 times daily): Pregabalin CR capsule capsule dose (dosed once a day)
  • 75 mg/daily: 82.5 mg/day
  • 150 mg/daily: 165 mg/day
  • 225 mg/daily: 247.5 mg/day
  • 300 mg/daily: 330 mg/day
  • 450 mg/daily: 495 mg/day
  • 600 mg/daily: 660 mg/day

Interaction

Pregabalin is unlikely to be involved in significant pharmacokinetic drug interactions.

Contraindications

Pregabalin is contraindicated in patients with known hypersensitivity to Pregabalin or any of its components.

Side Effects

Most common side effects in adults are dizziness, somnolence, dry mouth, edema, blurred vision, weight gain and thinking abnormal (primarily difficulty with concentration/attention). Most common side effects in pediatric patients for the treatment of partial onset seizures are increased weight and increased appetite.

Pregnancy & Lactation

There are no adequate and well-controlled studies with pregabalin in pregnant women. Pregnant women should be advised of the potential risk to a fetus. Small amounts of pregabalin have been detected in the milk of lactating women. Because of the potential risk of tumorigenicity, breastfeeding is not recommended during treatment with pregabalin.

Precautions & Warnings

Angioedema (e.g., swelling of the throat, head and neck) can occur and may be associated with life threatening respiratory compromise requiring emergency treatment. Pregabalin should be discontinued immediately in these cases. Pregabalin should also be discontinued immediately if hypersensitivity reactions (e.g., hives, dyspnea and wheezing) occur. Antiepileptic drugs, including pregabalin, increase the risk of suicidal thoughts or behavior. Respiratory depression may occur with pregabalin when used with concomitant CNS depressants or in the setting of underlying respiratory impairment. Patients need to be monitored and dosage adjusted as appropriate. Pregabalin may cause dizziness and somnolence and impair patients ability to drive or operate machinery. Increased seizure frequency or other adverse reactions may occur if pregabalin is rapidly discontinued. Pregabalin should be withdrawn gradually over a minimum of 1 week. Pregabalin may cause peripheral edema. Caution should be exercised when coadministering pregabalin and thiazolidinedione antidiabetic agents.

Overdose Effects

In case of overdose with pregabalin, sign and symptoms are reduced consciousness, depression/anxiety, confusional state, agitation and restlessness. Seizures and heart block have also been reported. There is no specific antidote. If indicated, elimination of unabsorbed drug may be attempted by emesis or gastric lavage; usual precautions should be observed to maintain the airway. General supportive care of the patient is indicated including monitoring of vital signs and observation of the clinical status of the patient.

Storage Conditions

Keep in a cool & dry place (below 30°C), protected from light & moisture. Keep out of the reach of children.

Alternative brands of Pregabalin

Other brands with the same generic name, cheapest first.

Gabarol Capsule

25 mg

Pregabalin

Advanced Chemical Industries PLC

৳ 11.00 per unit

Algaba Capsule

50 mg

Pregabalin

Al-Madina Pharmaceuticals Ltd.

৳ 12.00 per unit

See all 105 brands

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.